Page last updated: 2024-08-22

mannose and mart-1 antigen

mannose has been researched along with mart-1 antigen in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dobroff, AS; Moraes, JZ; Rodrigues, EG; Travassos, LR	1
Florindo, HF; Gaspar, M; Graca, L; Oliveira, VG; Préat, V; Salgado, A; Silva, JM; Vandermeulen, G; Videira, M; Zupancic, E	1

Other Studies

2 other study(ies) available for mannose and mart-1 antigen

Article	Year
Protective, anti-tumor monoclonal antibody recognizes a conformational epitope similar to melibiose at the surface of invasive murine melanoma cells. Hybridoma and hybridomics, 2002, Volume: 21, Issue:5 Topics: Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Neoplasm; Cancer Vaccines; Carbohydrate Metabolism; Carbohydrates; Cell Separation; Complement System Proteins; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Epitopes; Flow Cytometry; Galactose; Glutaral; Humans; Hybridomas; Immunoglobulin G; Immunotherapy; Lactose; Mannose; MART-1 Antigen; Melanoma; Melanoma, Experimental; Melibiose; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Fluorescence; Mucins; N-Acetylneuraminic Acid; Neoplasm Proteins; Protein Conformation; Trypanosoma cruzi	2002
In vivo delivery of peptides and Toll-like receptor ligands by mannose-functionalized polymeric nanoparticles induces prophylactic and therapeutic anti-tumor immune responses in a melanoma model. Journal of controlled release : official journal of the Controlled Release Society, 2015, Jan-28, Volume: 198 Topics: Animals; Cancer Vaccines; Cell Line, Tumor; Cytokines; Disease Models, Animal; Female; gp100 Melanoma Antigen; Granzymes; Immunoglobulin G; Ligands; Male; Mannose; MART-1 Antigen; Melanoma; Mice, Inbred C57BL; Mice, Transgenic; Nanoparticles; Oligodeoxyribonucleotides; Ovalbumin; Peptides; Poly I-C; Polymers; Toll-Like Receptors; Tumor Burden	2015

Article

Year

Protective, anti-tumor monoclonal antibody recognizes a conformational epitope similar to melibiose at the surface of invasive murine melanoma cells.

Hybridoma and hybridomics, 2002, Volume: 21, Issue:5

Topics: Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Neoplasm; Cancer Vaccines; Carbohydrate Metabolism; Carbohydrates; Cell Separation; Complement System Proteins; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Epitopes; Flow Cytometry; Galactose; Glutaral; Humans; Hybridomas; Immunoglobulin G; Immunotherapy; Lactose; Mannose; MART-1 Antigen; Melanoma; Melanoma, Experimental; Melibiose; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Fluorescence; Mucins; N-Acetylneuraminic Acid; Neoplasm Proteins; Protein Conformation; Trypanosoma cruzi

2002

In vivo delivery of peptides and Toll-like receptor ligands by mannose-functionalized polymeric nanoparticles induces prophylactic and therapeutic anti-tumor immune responses in a melanoma model.

Journal of controlled release : official journal of the Controlled Release Society, 2015, Jan-28, Volume: 198

Topics: Animals; Cancer Vaccines; Cell Line, Tumor; Cytokines; Disease Models, Animal; Female; gp100 Melanoma Antigen; Granzymes; Immunoglobulin G; Ligands; Male; Mannose; MART-1 Antigen; Melanoma; Mice, Inbred C57BL; Mice, Transgenic; Nanoparticles; Oligodeoxyribonucleotides; Ovalbumin; Peptides; Poly I-C; Polymers; Toll-Like Receptors; Tumor Burden

2015